Advanced search
Publication Cover
Hematology Volume 25, 2020 - Issue 1
Submit an article Journal homepage
2,097
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Prognostic factors for patients with multiple myeloma admitted to the intensive care unit

Xiangwen Diaoa Department of Emergency Medicine, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, People’s Republic of ChinaCorrespondence[email protected]
,
Ruibin Caia Department of Emergency Medicine, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, People’s Republic of China
,
Jieyu Luoa Department of Emergency Medicine, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, People’s Republic of China
,
Zhiwei Zhengb Ping An Life Insurance of China, Shenzhen, Guangdong, People’s Republic of China
&
Hong Zhana Department of Emergency Medicine, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, People’s Republic of ChinaCorrespondence[email protected]
Pages 433-437 | Published online: 19 Nov 2020

References

  • Smith D, Yong K. Multiple myeloma. Br Med J. 2013;346:f3863.
  • Mohty M, Cavo M, Fink L, et al. Understanding mortality in multiple myeloma: findings of a european retrospective chart review. EUR J Haematol. 2019;103:107–115.
  • Namendys-Silva SA, González-Herrera MO, García-Guillén FJ, et al. Outcome of critically ill patients with hematological malignancies. Ann Hematol. 2013;92:699–705.
  • Grgić Medić M, Gornik I, Gašparović V. Hematologic malignancies in the medical intensive care unit: outcomes and prognostic factors. Hematology. 2015;20:247–253.
  • Liu J, Cheng Q, Yang Q, et al. Prognosis-related factors in intensive care unit (ICU) patients with hematological malignancies: a retrospective cohort analysis in a Chinese population. Hematology. 2015;20:494–503.
  • Yeo CD, Kim JW, Kim SC, et al. Prognostic factors in critically ill patients with hematologic malignancies admitted to the intensive care unit. J Crit Care. 2012;27(739):e1–e6.
  • Azoulay E, Recher C, Alberti C, et al. Changing use of intensive care for hematological patients: the example of multiple myeloma. Intensive Care Med. 1999;25:1395–1401.
  • Hampshire PA, Welch CA, McCrossan LA, et al. Admission factors associated with hospital mortality in patients with haematological malignancy admitted to UK adult, general critical care units: a secondary analysis of the ICNARC case mix programme database. Crit Care. 2009;13:R137.
  • Johnson AE, Pollard TJ, Shen L, et al. MIMIC-III, a freely accessible critical care database. Sci Data. 2016;3:160035.
  • Vincent JL, Moreno R, Takala J, et al. The SOFA (sepsis-related organ failure Assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the European Society of intensive care Medicine. Intensive Care Med. 1996;22:707–710.
  • Johnson AE, Kramer AA, Clifford GD. A new severity of illness scale using a subset of acute physiology and chronic health evaluation data elements shows comparable predictive accuracy. Crit Care Med. 2013;41:1711–1718.
  • Feng M, McSparron JI, Kien DT, et al. Transthoracic echocardiography and mortality in sepsis: analysis of the MIMIC-III database. Intensive Care Med. 2018;44:884–892.
  • Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303–1310.
  • Iwashyna TJ, Odden A, Rohde J, et al. Identifying patients with severe sepsis using administrative claims: patient-level validation of the angus implementation of the international consensus conference definition of severe sepsis. Med Care. 2014;52:e39–e43.
  • Zhang Z. Missing data imputation: focusing on single imputation. Ann Transl Med. 2016;4:9.
  • Ferrà C, Marcos P, Misis M, et al. Outcome and prognostic factors in patients with hematologic malignancies admitted to the intensive care unit: a single-center experience. Int J Hemato. 2007;85:195–202.
  • Sculier JP, Paesmans M, Markiewicz E, et al. Scoring systems in cancer patients admitted for an acute complication in a medical intensive care unit. Crit Care Med. 2000;28:2786–2792.
  • Lemeshow S, Klar J, Teres D. Outcome prediction for individual intensive care patients: useful, misused, or abused? Intensive Care Med. 1995;21:770–776.
  • Larché J, Azoulay E, Fieux F, et al. Improved survival of critically ill cancer patients with septic shock. Intensive Care Med. 2003;29:1688–1695.
  • Friman V, Winqvist O, Blimark C, et al. Secondary immunodeficiency in lymphoproliferative malignancies. Hematol Oncol. 2016 2016-09-01;34(3):121–132.
  • SepNet Critical Care Trials Group. Incidence of severe sepsis and septic shock in German intensive care units: the prospective, multicentre INSEP study. Intensive Care Med. 2016;42:1980–1989.
  • van Beers EJ, Müller MC, Vlaar AP, et al. Van den Bergh WM; HEMA-ICU study group. Haematological malignancy in the intensive care unit: microbiology results and mortality. Eur J Haematol. 2016;97:271–277.
  • Massion PB, Dive AM, Doyen C, et al. Prognosis of hematologic malignancies does not predict intensive care unit mortality. Crit Care Med. 2002;30:2260–2270.
  • Wohlfarth P, Carlström A, Staudinger T, et al. Arbeitsgruppe für hämato-onkologische Intensivmedizin der Österreichischen Gesellschaft für Internistische und Allgemeine Intensivmedizin und Notfallmedizin (ÖGIAIN). Incidence of intensive care unit admission, outcome and post intensive care survival in patients with diffuse large B-cell lymphoma. Leuk Lymphoma. 2016;57:1831–1838.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.